Live Analyst Rating Changes 9331 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ryan Langston
TD
Ryan Langston
TD Cowen
Wall Street Analyst
★★★★☆
#657
on 13Foresight · ranked by our own returns
54%
Success Rate
+25.9%
Average Return
20 of 37 calls profitable · +22.7% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 54% of Ryan Langston's ratings turned a profit when each position was held for 1 year — averaging +25.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

78 Buy 48 Hold 0 Sell
Ryan's Stock Coverage 20 ratings · 2026-07-17
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
ACHC
Acadia Healthcare
 Jul 14, 2026 BUY Strong Buy
+26.2% avg upside
17 analysts
$36.00
11.59% Upside
 +0.0%
ASTH
Astrana Health
 Jul 14, 2026 BUY Strong Buy
+22.1% avg upside
16 analysts
$50.00
6.32% Upside
 -8.0%
ELV
Elevance Health
 Jul 14, 2026 BUY Strong Buy
+19.5% avg upside
33 analysts
$465.00
19.11% Upside
 -13.8%
UNH
UnitedHealth
 Jul 14, 2026 HOLD Strong Buy
+2.3% avg upside
36 analysts
$430.00
2.75% Upside
 -1.2%
MOH
Molina Healthcare
 Jul 14, 2026 HOLD Buy
+3.9% avg upside
26 analysts
$230.00
1.45% Downside
 +0.0%
HUM
Humana
 Jul 14, 2026 HOLD Buy
-10.5% avg upside
34 analysts
$350.00
14.12% Downside
 -5.0%
CNC
Centene
 Jul 14, 2026 HOLD Buy
+6.2% avg upside
29 analysts
$65.00
2.49% Downside
 -4.9%
THC
Tenet Healthcare
 Jun 25, 2026 BUY Strong Buy
+7.7% avg upside
26 analysts
$233.00
21.18% Upside
 -0.1%
HCA
HCA Healthcare
 Jun 25, 2026 BUY Buy
+6.7% avg upside
36 analysts
$431.00
13.83% Upside
 -1.8%
UHS
Universal Health
 Jun 22, 2026 BUY Buy
+35.1% avg upside
22 analysts
$197.00
33.03% Upside
 +7.6%
ADUS
Addus Homecare
 Jun 18, 2026 BUY Strong Buy
+13.4% avg upside
18 analysts
$131.00
18.85% Upside
 +20.4%
EHC
Encompass Health
 Jun 16, 2026 BUY Strong Buy
-0.7% avg upside
22 analysts
$125.00
13.70% Upside
 +12.9%
SGRY
Surgery Partners
 May 27, 2026 BUY Strong Buy
+48.8% avg upside
18 analysts
$17.00
7.08% Upside
 +12.2%
PIII
P3 Health Partners
 May 22, 2026 HOLD Buy
+1708.7% avg upside
8 analysts
$14.00
37.22% Upside
 -15.8%
DVA
DaVita
 May 11, 2026 HOLD Buy
-27.9% avg upside
17 analysts
$201.00
13.25% Downside
 +16.4%
PRVA
Privia Health Group
 May 11, 2026 BUY Strong Buy
+15.0% avg upside
26 analysts
$30.00
6.69% Upside
 +23.5%
ALHC
Alignment Healthcare
 May 04, 2026 BUY Strong Buy
+9.4% avg upside
19 analysts
$25.00
19.47% Upside
 +4.0%
AGL
Agilon Health
 Feb 27, 2026 HOLD Buy
-59.8% avg upside
26 analysts
$15.00
87.91% Downside
 +744.1%
CI
Cigna
 Feb 04, 2026 BUY Strong Buy
+20.9% avg upside
29 analysts
$333.00
11.75% Upside
 +10.8%
LFST
Lifestance Health Group
 Aug 09, 2024 HOLD Strong Buy
-8.0% avg upside
15 analysts
$7.00
36.21% Downside
 -22.0%
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ryan Langston — Frequently Asked Questions
How accurate are Ryan Langston's stock ratings?
Based on the calls 13Foresight could measure, about 56% of Ryan's ratings were profitable over a one-year hold, with an average return of +26.8% per rating, or +23.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ryan ranked on 13Foresight?
Ryan Langston is currently ranked #657 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ryan cover?
Ryan most recently has ratings on ACHC, ASTH, ELV, UNH, MOH, HUM, CNC, THC, HCA, UHS, ADUS, EHC and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.